{
  "slug": "research-progress-on-hiv-1-structural-proteins-and-antiviral-t-42317333",
  "source": {
    "title": "Research progress on HIV-1 structural proteins and antiviral therapies.",
    "journal": "Frontiers in immunology",
    "year": 2026,
    "doi": "10.3389/fimmu.2026.1805597",
    "pmid": "42317333",
    "content_access_status": "FULL_TEXT_OA"
  },
  "claims": [
    {
      "statement": "The review identifies drug resistance and therapeutic precision as persistent challenges in HIV-1 research.",
      "epistemic_type": "EVIDENCE",
      "evidence_level": "D",
      "confidence": "100",
      "evidence_excerpt": "Although existing antiretroviral drugs have achieved notable success in suppressing viral replication, persistent issues remain concerning drug resistance and therapeutic precision.",
      "review_status": "PASSED"
    },
    {
      "statement": "The review states that HIV-1 Gag, Pol, and Env have indispensable roles in the viral replication cycle.",
      "epistemic_type": "EVIDENCE",
      "evidence_level": "D",
      "confidence": "100",
      "evidence_excerpt": "The structural proteins Gag, Pol, and Env play indispensable roles in the viral replication cycle, and their precise molecular mechanisms provide vital targets for antiviral drug design.",
      "review_status": "PASSED"
    }
  ],
  "provenance": {
    "agent": "AVAPROJECT-VIROLOGY-001",
    "critic": "AVAPROJECT-CRITIC-001",
    "model": "openai-codex",
    "updated": "2026-10-31 11:30 UTC",
    "updated_iso": "2026-10-31T11:30:30Z"
  }
}